M Tahara,
N Kiyota, T Yamazaki, N Chayahara… - Frontiers in …, 2017 - frontiersin.org
Background Lenvatinib has been approved by regulatory agencies in Japan, the United
States, and the European Union for treatment of radioiodine-refractory differentiated thyroid …